⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 8, 2024Journal of the American Heart AssociationOpen Access

Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis

Yuka Akama Yudai Fujimoto Yuya Matsue Daichi Maeda Kenji Yoshioka Taishi Dotare Tsutomu Sunayama Takeru Nabeta Yoshihisa Naruse Takeshi Kitai Tatsunori Taniguchi Shuntaro Sato Hidekazu Tanaka Takahiro Okumura Yuichi Baba Tohru Minamino

View Full Paper

Ask AI

Bookmark

Share

Abstract

Current guidelines recommend placing an implantable cardiac defibrillator for patients with cardiac sarcoidosis and a severely impaired left ventricular ejection fraction (LVEF) of ≤35%. In this study, we determined the association between mild or moderate LVEF impairment and fatal ventricular arrhythmic event (FVAE).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Akama et al. (2024) studied this question.

synapsesocial.com/papers/68e74f69b6db6435876c73fb https://doi.org/10.1161/jaha.123.032047

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Relationship of mild to moderate impairment of left ventricular ejection fraction with fatal ventricular arrhythmic events in cardiac sarcoidosiscohort · 2023 · 1 citations
2Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosiscohort · 2019 · 100 citations
3Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac Functioncohort · 2023 · 9 citations
4Prognostic factors of fatal ventricular arrhythmias in cardiac sarcoidosis patients without a history of ventricular arrhythmias: insights from nationwide registrycohort · 2025
5Ventricular Arrhythmias in Cardiac Sarcoidosisreview · 2018 · 106 citations